 Rebecca Hanratty
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 7 | 2022 | 1273 | 0.680 |
Why?
| | Safety-net Providers | 4 | 2024 | 130 | 0.610 |
Why?
| | Kidney Diseases | 2 | 2011 | 425 | 0.480 |
Why?
| | Patient Discharge | 2 | 2020 | 992 | 0.450 |
Why?
| | Analgesics, Opioid | 3 | 2022 | 1149 | 0.390 |
Why?
| | Specialization | 1 | 2013 | 135 | 0.360 |
Why?
| | Pharmacy Service, Hospital | 1 | 2013 | 89 | 0.350 |
Why?
| | Electronic Health Records | 3 | 2024 | 1196 | 0.350 |
Why?
| | Medically Underserved Area | 2 | 2010 | 100 | 0.330 |
Why?
| | Patient-Centered Care | 2 | 2013 | 547 | 0.330 |
Why?
| | Telemedicine | 1 | 2020 | 961 | 0.330 |
Why?
| | Antihypertensive Agents | 4 | 2021 | 519 | 0.330 |
Why?
| | Registries | 5 | 2024 | 2406 | 0.320 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 297 | 0.320 |
Why?
| | Racism | 3 | 2021 | 146 | 0.300 |
Why?
| | Community Health Workers | 1 | 2010 | 88 | 0.300 |
Why?
| | Blood Pressure | 3 | 2014 | 1779 | 0.290 |
Why?
| | Social Values | 2 | 2021 | 40 | 0.260 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 95 | 0.260 |
Why?
| | Colorado | 12 | 2024 | 4553 | 0.260 |
Why?
| | Medication Adherence | 4 | 2022 | 540 | 0.250 |
Why?
| | Community Health Services | 1 | 2008 | 231 | 0.240 |
Why?
| | Kidney | 2 | 2011 | 1497 | 0.220 |
Why?
| | Health Promotion | 1 | 2010 | 775 | 0.200 |
Why?
| | Opioid-Related Disorders | 2 | 2022 | 602 | 0.200 |
Why?
| | Risk Assessment | 5 | 2021 | 3747 | 0.200 |
Why?
| | Patient Readmission | 2 | 2021 | 769 | 0.180 |
Why?
| | Middle Aged | 19 | 2024 | 36215 | 0.180 |
Why?
| | Pharmacies | 1 | 2022 | 40 | 0.170 |
Why?
| | Epidemics | 1 | 2022 | 96 | 0.170 |
Why?
| | Cardiovascular Diseases | 2 | 2010 | 2187 | 0.170 |
Why?
| | Referral and Consultation | 2 | 2024 | 867 | 0.160 |
Why?
| | Language | 1 | 2024 | 323 | 0.160 |
Why?
| | Prescriptions | 1 | 2020 | 74 | 0.160 |
Why?
| | Hospitalization | 2 | 2023 | 2460 | 0.160 |
Why?
| | Retrospective Studies | 9 | 2022 | 17291 | 0.160 |
Why?
| | Algorithms | 1 | 2008 | 1845 | 0.150 |
Why?
| | Aged | 12 | 2024 | 26153 | 0.150 |
Why?
| | Adult | 16 | 2024 | 40777 | 0.150 |
Why?
| | Physician-Patient Relations | 3 | 2013 | 588 | 0.150 |
Why?
| | Buprenorphine | 1 | 2022 | 191 | 0.140 |
Why?
| | Substance-Related Disorders | 2 | 2024 | 1102 | 0.140 |
Why?
| | Inpatients | 1 | 2023 | 553 | 0.140 |
Why?
| | Humans | 26 | 2024 | 145474 | 0.140 |
Why?
| | Attitude to Health | 1 | 2021 | 430 | 0.140 |
Why?
| | Patient Satisfaction | 2 | 2013 | 709 | 0.140 |
Why?
| | Male | 20 | 2024 | 72842 | 0.130 |
Why?
| | Medical Overuse | 1 | 2018 | 30 | 0.130 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 124 | 0.130 |
Why?
| | Hospitals, Urban | 1 | 2018 | 142 | 0.130 |
Why?
| | Drug Overdose | 1 | 2022 | 374 | 0.130 |
Why?
| | Female | 20 | 2024 | 78844 | 0.130 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 765 | 0.120 |
Why?
| | Models, Statistical | 2 | 2018 | 671 | 0.120 |
Why?
| | Hospitals | 1 | 2020 | 732 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 609 | 0.110 |
Why?
| | Incidence | 3 | 2011 | 2923 | 0.110 |
Why?
| | Risk Factors | 6 | 2021 | 10885 | 0.100 |
Why?
| | Primary Health Care | 3 | 2014 | 1735 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 527 | 0.100 |
Why?
| | Electrocardiography | 3 | 2020 | 665 | 0.100 |
Why?
| | Blood Pressure Determination | 1 | 2014 | 145 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1210 | 0.090 |
Why?
| | Telephone | 1 | 2013 | 177 | 0.090 |
Why?
| | Healthcare Disparities | 4 | 2024 | 735 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1707 | 0.090 |
Why?
| | Hyperlipidemias | 1 | 2012 | 120 | 0.090 |
Why?
| | Professional Role | 1 | 2013 | 169 | 0.090 |
Why?
| | Time Factors | 3 | 2012 | 7123 | 0.080 |
Why?
| | Follow-Up Studies | 3 | 2022 | 5423 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1371 | 0.080 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 155 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1327 | 0.080 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 208 | 0.080 |
Why?
| | Community-Institutional Relations | 1 | 2010 | 100 | 0.080 |
Why?
| | Young Adult | 5 | 2024 | 14218 | 0.070 |
Why?
| | Linear Models | 1 | 2011 | 845 | 0.070 |
Why?
| | Risk Reduction Behavior | 1 | 2010 | 217 | 0.070 |
Why?
| | Minority Groups | 1 | 2010 | 284 | 0.070 |
Why?
| | Life Style | 1 | 2010 | 485 | 0.070 |
Why?
| | Risk | 1 | 2010 | 919 | 0.070 |
Why?
| | Diabetes Complications | 1 | 2009 | 224 | 0.070 |
Why?
| | United States | 5 | 2024 | 16098 | 0.070 |
Why?
| | Comorbidity | 2 | 2012 | 1661 | 0.060 |
Why?
| | Drug Prescriptions | 1 | 2009 | 288 | 0.060 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1323 | 0.060 |
Why?
| | Length of Stay | 1 | 2013 | 1349 | 0.060 |
Why?
| | Vascular Diseases | 1 | 2009 | 252 | 0.060 |
Why?
| | Urban Health Services | 2 | 2021 | 69 | 0.060 |
Why?
| | Communication | 1 | 2012 | 975 | 0.060 |
Why?
| | Logistic Models | 3 | 2021 | 2134 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8333 | 0.060 |
Why?
| | Drug Monitoring | 1 | 2009 | 401 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2012 | 946 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2010 | 777 | 0.060 |
Why?
| | Odds Ratio | 2 | 2021 | 1082 | 0.050 |
Why?
| | Survival Analysis | 1 | 2008 | 1374 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1193 | 0.050 |
Why?
| | Confidentiality | 1 | 2024 | 80 | 0.050 |
Why?
| | Disease Progression | 1 | 2011 | 2864 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 1097 | 0.050 |
Why?
| | Chronic Disease | 1 | 2009 | 1808 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1399 | 0.050 |
Why?
| | Prognosis | 1 | 2011 | 4316 | 0.050 |
Why?
| | Cohort Studies | 2 | 2009 | 6013 | 0.040 |
Why?
| | Mass Screening | 1 | 2010 | 1360 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 79 | 0.040 |
Why?
| | Data Collection | 1 | 2024 | 640 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2013 | 536 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2021 | 318 | 0.040 |
Why?
| | Health Maintenance Organizations | 2 | 2012 | 105 | 0.040 |
Why?
| | Naloxone | 1 | 2022 | 131 | 0.040 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 147 | 0.040 |
Why?
| | Writing | 1 | 2021 | 101 | 0.040 |
Why?
| | Chest Pain | 1 | 2020 | 99 | 0.040 |
Why?
| | Opiate Substitution Treatment | 1 | 2022 | 188 | 0.040 |
Why?
| | Narcotic Antagonists | 1 | 2022 | 203 | 0.040 |
Why?
| | Adolescent | 3 | 2013 | 22529 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1163 | 0.040 |
Why?
| | Pharmacists | 1 | 2022 | 258 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2021 | 321 | 0.030 |
Why?
| | Self Report | 1 | 2022 | 870 | 0.030 |
Why?
| | Stereotyped Behavior | 1 | 2012 | 21 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1419 | 0.020 |
Why?
| | Cultural Competency | 1 | 2013 | 88 | 0.020 |
Why?
| | Trust | 1 | 2012 | 155 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2012 | 360 | 0.020 |
Why?
| | Affect | 1 | 2012 | 320 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2381 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1891 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 283 | 0.020 |
Why?
| | Nutrition Surveys | 1 | 2008 | 279 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 2865 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1547 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2121 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 2090 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 4295 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 11772 | 0.010 |
Why?
|
|
Hanratty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|